CLINICAL_TRIALS
trial_result
· 2011-07-07
Clinical Trial Update: Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan [Phase 2]
Summary
This report summarizes long-term safety data for alogliptin in Japanese participants with type 2 diabetes from a Phase 2 trial.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2011-07-07